Sullivan Louis W insider trades
Sullivan Louis W has filed 24 Form 4s with the SEC that we hold, for UNITED THERAPEUTICS Corp (UTHR) (Director) and Emergent BioSolutions Inc. (EBS) (Director). Across all of them we count 0 purchases worth $0 and 39 sales worth $17.7M reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($3.0M). The largest single trade was a sale of 4,863 shares of UNITED THERAPEUTICS Corp worth $2.5M, dated 2025-12-22. The first filing on our record is dated 2021-07-09 and the latest 2026-07-23.
UNITED THERAPEUTICS Corp (UTHR)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-05-26 | S, sale reported on Form 4 | 1,345 | $305.0K | 2022-05-26 |
| 2022-05-26 | S, sale reported on Form 4 | 1,699 | $379.5K | 2022-05-26 |
| 2022-05-26 | S, sale reported on Form 4 | 1,766 | $396.3K | 2022-05-26 |
| 2022-05-26 | S, sale reported on Form 4 | 1,500 | $339.1K | 2022-05-26 |
| 2022-09-02 | S, sale reported on Form 4 | 4,910 | $1.1M | 2022-09-06 |
| 2022-10-03 | S, sale reported on Form 4 | 710 | $150.2K | 2022-10-03 |
| 2022-11-01 | S, sale reported on Form 4 | 700 | $161.2K | 2022-11-02 |
| 2022-12-01 | S, sale reported on Form 4 | 700 | $195.9K | 2022-12-01 |
| 2023-01-03 | S, sale reported on Form 4 | 700 | $193.4K | 2023-01-03 |
| 2023-02-01 | S, sale reported on Form 4 | 700 | $182.9K | 2023-02-02 |
| 2023-03-01 | S, sale reported on Form 4 | 700 | $171.6K | 2023-03-02 |
| 2024-05-03 | S, sale reported on Form 4 | 2,979 | $771.9K | 2024-05-06 |
| 2024-05-03 | S, sale reported on Form 4 | 2,181 | $561.4K | 2024-05-06 |
| 2024-12-18 | S, sale reported on Form 4 | 752 | $277.2K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 1,926 | $712.7K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 100 | $38.3K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 620 | $236.5K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 700 | $266.1K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 200 | $75.9K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 500 | $187.2K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 2,200 | $825.0K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 2,451 | $917.0K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 200 | $74.2K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 1,501 | $560.1K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 1,400 | $518.4K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 2,100 | $775.6K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 1,307 | $481.6K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 600 | $220.2K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 1,121 | $410.4K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 100 | $38.2K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 800 | $305.1K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 944 | $358.4K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 400 | $151.0K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 2,700 | $1.0M | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 1,962 | $734.1K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 100 | $37.1K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 1,525 | $568.9K | 2024-12-19 |
| 2025-12-22 | S, sale reported on Form 4 | 4,863 | $2.5M | 2025-12-23 |
| 2025-12-22 | S, sale reported on Form 4 | 1,087 | $555.7K | 2025-12-23 |
Emergent BioSolutions Inc. (EBS)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1193522) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms